India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Sirius JV will be owned 51% by Sirius and 49% by Adani
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
India presents one of the world’s largest untapped opportunities for neurovascular screening
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
This integrated center combines development, testing, evaluation, and industry-academia-research collaboration
Subscribe To Our Newsletter & Stay Updated